Literature DB >> 2836553

The effect of sequences in the 5' non-coding region on the replication of polioviruses in the human gut.

P D Minor1, G Dunn.   

Abstract

The genomic sequences of a portion of the 5' non-coding region of polioviruses excreted by recipients of the Sabin vaccine strains of poliovirus were examined. It was found that in all three types a residue changed in the course of excretion to give a sequence representing the consensus of poliovirus sequences. For type 1 this residue was at position 481, which altered in half the vaccines, for type 2 it was at position 480, which altered in all vaccinees and for type 3 it was at position 472 in all vaccinees, as previously reported. Other vaccine strains unrelated to the Sabin strains but used in limited vaccination programmes did not have such changing residues. It was concluded that these regions indicated sequences that were strongly selected during replication in the human gut. Such sequences were further defined by examination of strains of poliovirus unrelated to the vaccine strains, the sequences of which may be expected to vary at less stringently defined regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2836553     DOI: 10.1099/0022-1317-69-5-1091

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  27 in total

1.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA.

Authors:  A A Haller; B L Semler
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Enteroviruses in recreational waters of Northern Ireland.

Authors:  M S Hughes; P V Coyle; J H Connolly
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

5.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Long-term excretion of vaccine-derived poliovirus by a healthy child.

Authors:  Javier Martín; Kofi Odoom; Gráinne Tuite; Glynis Dunn; Nicola Hopewell; Gill Cooper; Catherine Fitzharris; Karina Butler; William W Hall; Philip D Minor
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Shedding and reversion of oral polio vaccine type 3 in Mexican vaccinees: comparison of mutant analysis by PCR and enzyme cleavage to a real-time PCR assay.

Authors:  Devasena Gnanashanmugam; Meira S Falkovitz-Halpern; Anthony Dodge; Melanie Fang; Lisa J Wong; Melissa Esparza; Rebecca Hammon; Enrique E Rivas-Merelles; Jose I Santos; Yvonne Maldonado
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

8.  Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.

Authors:  Cara Carthel Burns; Jing Shaw; Ray Campagnoli; Jaume Jorba; Annelet Vincent; Jacqueline Quay; Olen Kew
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Identification of vaccine-related polioviruses by hybridization with specific RNA probes.

Authors:  L De; B Nottay; C F Yang; B P Holloway; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.